跳至主要内容
临床试验/NCT05977621
NCT05977621
招募中
不适用

Acquisition of Trans-Rectal Ultrasound [TRUS] Images of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking for Image-Guided Brachytherapy: A Pre-feasibility Study

Duke University1 个研究点 分布在 1 个国家目标入组 17 人2024年2月7日

概览

阶段
不适用
干预措施
Transrectal ultrasound (TRUS)
疾病 / 适应症
Uterine Cancer
发起方
Duke University
入组人数
17
试验地点
1
主要终点
Number of patients whose MRI and ultrasound images are fused
状态
招募中
最后更新
上个月

概览

简要总结

The purpose of this study is to utilize transrectal ultrasound (TRUS) images of the intact and post-hysterectomy female pelvis in order to provide feasibility information for a Magnetic Resonance Imaging (MRI)-TRUS fusion based 3D needle navigation system for use in image guided brachytherapy. The fusion and needle guidance will be performed using Eigen Health's navigation system that currently provides targeted MR/Ultrasound fusion based prostate biopsies utilizing a proprietary 3D semi-robotic navigation system.

注册库
clinicaltrials.gov
开始日期
2024年2月7日
结束日期
2027年3月1日
最后更新
上个月
研究类型
Observational
性别
Female

研究者

责任方
Sponsor

入排标准

入选标准

  • Histologically proven invasive primary squamous, adenosquamous, or adenocarcinoma of the uterine cervix, (recurrent or medically inoperable) uterine adenocarcinoma.
  • Treatment plan must include curative-intent definitive radiation that includes brachytherapy treatments with or without concurrent chemotherapy
  • Adults ≥ 18 years of age
  • ECOG Performance Status 0-2

排除标准

  • Patients with active rectal bleeding or rectal ulcer

研究组 & 干预措施

Intact anatomy

Patients with intact anatomy (uterus and cervix)

干预措施: Transrectal ultrasound (TRUS)

Post-hysterectomy

Post-hysterectomy patients (vaginal cuff) who are planned to receive brachytherapy

干预措施: Transrectal ultrasound (TRUS)

结局指标

主要结局

Number of patients whose MRI and ultrasound images are fused

时间窗: up to 5 weeks

研究点 (1)

Loading locations...

相似试验